Extracardial Vasculopathy After Kawasaki Disease: A Long-Term Follow-up Study

Sanne M Dietz1, Carline E Tacke2, Eric de Groot3

  • 1Department of Pediatric Hematology, Immunology and Infectious Diseases, Emma Children's Hospital, Academic Medical Center (AMC), Amsterdam, The Netherlands s.m.dietz@amc.uva.nl.

Insights

Kawasaki disease (KD) patients show increased carotid intima-media thickness (cIMT), a marker of cardiovascular risk. While cIMT normalizes in some, those with giant coronary artery aneurysms (CAA) may experience persistently elevated cIMT, requiring long-term cardiac monitoring.

Area of Science:

  • Pediatric Cardiology
  • Vascular Biology
  • Rheumatology

Background:

  • Kawasaki disease (KD) is a significant pediatric vasculitis.
  • Coronary artery aneurysm (CAA) is a major complication of KD.
  • Long-term cardiovascular risk in KD patients remains a subject of debate.

Purpose of the Study:

  • To assess the long-term cardiovascular risk in KD patients.
  • To evaluate if KD patients exhibit increased carotid intima-media thickness (cIMT).
  • To correlate cIMT with KD severity and CAA presence.

Main Methods:

  • A 15-year longitudinal study measuring cIMT using B-mode ultrasonography.
  • Comparison of 319 KD patients with 150 unaffected controls.
  • Analysis using a multilevel, repeated-measures, linear mixed-effects model.

Main Results:

  • KD patients exhibited significantly increased mean cIMT compared to controls.
  • Increased cIMT was observed across all KD subgroups, including CAA-negative patients.
  • While cIMT normalized in CAA-negative patients over time, those with giant CAA showed a trend towards persistently increased cIMT progression.

Conclusions:

  • KD is associated with increased cIMT, indicating heightened cardiovascular risk.
  • Initially elevated cIMT in CAA-negative patients normalizes later in life.
  • Patients with giant CAA may require ongoing cardiovascular surveillance due to persistently elevated cIMT.
Abstract

Related Concept Videos

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
946
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
325
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
384